Patents by Inventor Michel Obringer

Michel Obringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
    Patent number: 11491148
    Abstract: The application relates to amide derivatives of formula (I), processes for their preparation, pharmaceutical compositions, and their uses, more particularly their uses in treating chronic hepatitis B virus (HBV) infection:
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: November 8, 2022
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Bart Rudolf Romanie Kesteleyn, Jan Martin Berke, Erwin Coesemans, Sandrine Céline Grosse, Edgar Jacoby, Tim Hugo Maria Jonckers, Stefaan Julien Last, Wim Gaston Verschueren, Michel Obringer, Christelle Catherine Cecile Doebelin
  • FUSED HETEROCYCLE DERIVATIVES
    Publication number: 20220242879
    Abstract: The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.
    Type: Application
    Filed: May 27, 2020
    Publication date: August 4, 2022
    Inventors: Scott D. KUDUK, Christelle Catherine Cecile DOEBELIN, Abdellah TAHRI, Sandrine Céline GROSSE, Stefaan Julien LAST, Lindsey Graham DERATT, Koen VANDYCK, Pierre Jean-Marie Bernard RABOISSON, Jan Martin BERKE, Wim Gaston VERSCHUEREN, Michel OBRINGER
  • AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES
    Publication number: 20200352925
    Abstract: The application relates to amide derivatives, processes for their preparation, pharmaceutical compositions, and their uses, more particularly their uses in treating chronic hepatitis B virus (HBV) infection.
    Type: Application
    Filed: May 5, 2020
    Publication date: November 12, 2020
    Inventors: Bart Rudolf Romanie KESTELEYN, Jan Martin BERKE, Erwin COESEMANS, Sandrine Céline GROSSE, Edgar JACOBY, Tim Hugo Maria JONCKERS, Stefaan Julien LAST, Wim Gaston VERSCHUEREN, Michel OBRINGER, Christelle Catherine Cecile DOEBELIN
  • Naphthyridine derivative compounds
    Patent number: 9757364
    Abstract: The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: September 12, 2017
    Assignee: ASTEX THERAPEUTICS LTD
    Inventors: Patrick René Angibaud, Michel Obringer, Julien Jérémie Joseph Marin, Matthieu Jeanty
  • NEW COMPOUNDS
    Publication number: 20170105978
    Abstract: The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: October 31, 2016
    Publication date: April 20, 2017
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick René ANGIBAUD, Michel OBRINGER, Julien Jérémie Joseph MARIN, Matthieu JEANTY
  • Naphthyridine derivative compounds
    Patent number: 9527844
    Abstract: The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: December 27, 2016
    Assignee: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick Rene Angibaud, Michel Obringer, Julien Jeremie Joseph Marin, Matthieu Jeanty
  • NAPHTHYRIDINE DERIVATIVE COMPOUNDS
    Publication number: 20160108034
    Abstract: The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: September 16, 2015
    Publication date: April 21, 2016
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick Rene ANGIBAUD, Michel OBRINGER, Julien Jeremie Joseph MARIN, Matthieu JEANTY
  • Naphthyridine derivative compounds
    Patent number: 9309241
    Abstract: The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: April 12, 2016
    Assignee: ASTEX THERAPEUTICS LTD
    Inventors: Patrick Rene Angibaud, Michel Obringer, Julien Jeremie Joseph Marin, Matthieu Jeanty
  • NEW COMPOUNDS
    Publication number: 20150057293
    Abstract: The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: October 26, 2012
    Publication date: February 26, 2015
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick Rene Angibaud, Michel Obringer, Julien Jeremie Joseph Marin, Matthieu Jeanty